about
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several c...
Read More
110.23
1.43
(1.31%)
420.6K
XNAS Volume
XNAS 27 Feb, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for BioNTech SE (ADR) is on 10 Mar 2026 for the purpose of BioNTech SE Fourth Quarter Earnings Result for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
BioNTech SE (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..